AzTrials
AzTrials

Alcohol-Induced DisordersTRACNCT05787106

Role of Adverse Childhood Events and Rejection Sensitivity on Alcohol Use in Recently Withdrawn Individuals With Alcohol Use Disorder

A study testing Cyberball task in people with Alcohol-Induced Disorders and Ostracism, run by Centre Hospitalier Universitaire de Nīmes at 1 site in France.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Low utilization of addiction treatment is a public health problem. A number of factors are associated with lack of treatment, including public stigma, self-stigma, and beliefs that people with addiction should solve their problem on their own. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Alcohol-Induced Disorders, Ostracism
What is being tested?
Cyberball task
Could I receive a placebo?
No, everyone receives an active treatment
How many people
58 participants
Where
1 siteFrance
Study dates
31 May 2023to Nov 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient admitted to the Grau-du-Roi Follow-up and Rehabilitation Care Service.
  • Patient abstinent from alcohol for at least 10 days.
  • The patient must have given their free and informed consent and signed the consent form
  • The patient must be a member or beneficiary of a health insurance plan

Who cannot join

  • Other mental health disorder: bipolar disorder, schizophrenia, severe acute depression, borderline personality.
  • Severe substance use disorder (SUD).
  • Current suicidal ideation as judged by clinician.
  • Patient unable to give consent.
  • Pregnant or breastfeeding patient.
  • The subject is participating in a Category 1 interventional study, or is in a period of exclusion determined by a previous study
  • It is impossible to give the subject informed information
  • The patient is under safeguard of justice or state guardianship

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU de Nîmes

    Nîmes, Nîmes, 30029

Other trials in France

About this study

Low utilization of addiction treatment is a public health problem. A number of factors are associated with lack of treatment, including public stigma, self-stigma, and beliefs that people with addiction should solve their problem on their own. Stigma exposes individuals to social rejection, which may sustain the anxiety of rejection, and exacerbate certain mental disorders such as addictions. Social cognition disorders have been shown to be present in addictions, but one dimension of social cognition, emotional sensitivity to rejection (ESR), has been less studied. Rejection sensitivity could be considered a critical element in access to care and the relapse process.

The study authors hypothesize a role for emotional dysregulation in rejection situations in the relapse of alcohol use disorder in recently withdrawn patients. Specifically, they hypothesize that participants with a greater change in negative experience after a rejection situation on a Cyberball task, as measured by the negative subscale of the Positive and Negative Affect Schedule (PANAS), will have a higher percentage of days with heavy drinking during the last four weeks to three months of follow-up.

Being tested
Cyberball task
Keywords
Adverse childhood experiences, Rejection
Medical subject headings
Alcohol-Induced Disorders, Ostracism, Rejection, Psychology

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cyberball taskOther

    The game consists of ball throws between animated characters lasting about 50 throws. In the rejection condition, after 2 or 3 throws, the participant no longer receives the ball (no more passes). In the control conditions ("all included"), the participant receives the ball as often as the others.

Study groups in NCT05787106
Study groupRoleWhat they receive
PAtients withdrawn from alcoholExperimentalNot described
Receives: Other: Cyberball task

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Role of emotional reaction to social rejection (Cyberball game)

    Positive And Negative Affect Schedule (PANAS) (negative affect score). Scores can range from 10 to 50 for positive and negative emotions, with lower scores representing lower levels of positive/negative emotional engagement and higher scores representing higher levels of positive/negative emotional engagement.

    Measured: Day 0; before Cyberball task

  2. Role of emotional reaction to social rejection (Cyberball game)

    Positive And Negative Affect Schedule (PANAS) (negative affect score). Scores can range from 10 to 50 for positive and negative emotions, with lower scores representing lower levels of positive/negative emotional engagement and higher scores representing higher levels of positive/negative emotional engagement.

    Measured: Day 0; after Cyberball task

  3. Percentage of heavy drinking days in the past 4 weeks

    Timeline Follow Back (TLFB) interview

    Measured: Month 3

  4. Correlation between percentage of heavy drinking days and the difference between the PANAS negative subscale scores at baseline and after the Cyberball task in the exclusion phase (=rejection situation).

    Multiple linear regression

    Measured: Day 0; before Cyberball task

  5. Correlation between percentage of heavy drinking days and the difference between the PANAS negative subscale scores at baseline and after the Cyberball task in the exclusion phase (=rejection situation).

    Multiple linear regression

    Measured: Day 0; after Cyberball task

  6. Correlation between percentage of heavy drinking days and the difference between the PANAS negative subscale scores at baseline and after the Cyberball task in the exclusion phase (=rejection situation).

    Multiple linear regression

    Measured: Month 3

Secondary outcomes (27)
  1. Adverse childhood events

    Adverse childhood events (ACE) score

    Measured: Day 0

  2. Patient level of distress due to rejection

    Need Threat Scale (NTS) score

    Measured: Day 0; after Cyberball task

  3. Patient self-stigma due to alcohol dependence

    Self-stigma in Alcohol Dependence (SSAD) scale score

    Measured: Day 0

  4. Patient depression

    Patient Health Questionnaire (PHQ-9) score

    Measured: Day 0

  5. Patient depression

    Patient Health Questionnaire (PHQ-9) score

    Measured: Month 3

  6. Patient depression

    Patient Health Questionnaire (PHQ-9) score

    Measured: Month 6

  7. Patient depression

    Patient Health Questionnaire (PHQ-9) score

    Measured: Month 12

  8. Patient anxiety

    Generalized Anxiety Disorder-7 (GAD-7) score

    Measured: Day 0

  9. Patient anxiety

    Generalized Anxiety Disorder-7 (GAD-7) score

    Measured: Month 3

  10. Patient anxiety

    Generalized Anxiety Disorder-7 (GAD-7) score

    Measured: Month 6

  11. Patient anxiety

    Generalized Anxiety Disorder-7 (GAD-7) score

    Measured: Month 12

  12. Number of days of alcohol consumption in the past 4 weeks

    Timeline Follow Back (TLFB) interview

    Measured: Month 3

  13. Number of days of alcohol consumption in the past 4 weeks

    Timeline Follow Back (TLFB) interview

    Measured: Month 6

  14. Number of days of alcohol consumption in the past 4 weeks

    Timeline Follow Back (TLFB) interview

    Measured: Month 12

  15. Number of days of heavy alcohol consumption in the past 4 weeks

    Timeline Follow Back (TLFB) interview

    Measured: Month 3

  16. Number of days of heavy alcohol consumption in the past 4 weeks

    Timeline Follow Back (TLFB) interview

    Measured: Month 6

  17. Number of days of heavy alcohol consumption in the past 4 weeks

    Timeline Follow Back (TLFB) interview

    Measured: Month 12

  18. Percentage of heavy drinking days in the past 4 weeks

    Timeline Follow Back (TLFB) interview

    Measured: Month 3

  19. Percentage of heavy drinking days in the past 4 weeks

    Timeline Follow Back (TLFB) interview

    Measured: Month 6

  20. Percentage of heavy drinking days in the past 4 weeks

    Timeline Follow Back (TLFB) interview

    Measured: Month 12

  21. Lifetime history of suicide attempts

    Number

    Measured: Day 0

  22. Current treatments

    List of current treatments taken from patient medical file

    Measured: Day 0

  23. Patient dispositional (i.e. trait) empathy

    Interpersonal reactivity index (IRI) score

    Measured: Day 0

  24. Concurrent validity of the Adult rejection Sensitivity Questionnaire (A-RSQ) with the Positive And Negative Affect Schedule (PANAS) after the rejection situation.

    Measured: Day 0; before Cyberball task

  25. Concurrent validity of the Adult rejection Sensitivity Questionnaire (A-RSQ) with the Positive And Negative Affect Schedule (PANAS) after the rejection situation.

    Measured: Day 0; after Cyberball task

  26. Concurrent validity of the Adult rejection Sensitivity Questionnaire (A-RSQ) with the Need Threat Scale (NTS) after the rejection situation.

    Measured: Day 0; before Cyberball task

  27. Concurrent validity of the Adult rejection Sensitivity Questionnaire (A-RSQ) with the Need Threat Scale (NTS) after the rejection situation.

    Measured: Day 0; after Cyberball task

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Mar 2023
  2. Study start31 May 2023
  3. Primary completion15 Jan 2025
  4. Study completionNov 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
58 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05787106
Sponsor's protocol ID
NIMAO/2022-2/AL-01
Acronym
TRAC
Status last verified
Feb 2025
First submitted
13 Mar 2023
Last updated
13 Feb 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Cyberball task in people with Alcohol-Induced Disorders and Ostracism, run by Centre Hospitalier Universitaire de Nīmes at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 13 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Role of emotional reaction to social rejection (Cyberball game) (time frame: Day 0; before Cyberball task). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Feb 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in